Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.

Andreas Mangold; Anna S Ondracek; Thomas M Hofbauer; Tyler Artner; Johanna Nechvile; Noel G Panagiotides; Moritz Mirna; Matthias Hammerer; Dzeneta Fejzic; Uta Hoppe; Bernhard Wernly; Alexander Lauten; Brunilda Alushi; Marcus Franz; Paul C Schulze; Evelyne Wohlschläger-Krenn; Irene M Lang; Michael Lichtenauer

doi:10.1111/eci.13595

Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.

Andreas Mangold, Anna S Ondracek, Thomas M Hofbauer, Tyler Artner, Johanna Nechvile, Noel G Panagiotides, Moritz Mirna (Co-author), Matthias Hammerer (Co-author), Dzeneta Fejzic (Co-author), Uta Hoppe (Co-author), Bernhard Wernly (Co-author), Alexander Lauten, Brunilda Alushi, Marcus Franz, Paul C Schulze, Evelyne Wohlschläger-Krenn, Irene M Lang, Michael Lichtenauer (Last author)

Department of Internal Medicine II - Division of Cardiology

Research output: Contribution to journal › Original Article › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	e13595
Journal	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume	51
Issue number	11
DOIs	https://doi.org/10.1111/eci.13595
Publication status	Published - 2021

Keywords

NEUTROPHIL EXTRACELLULAR TRAPS
PREDICTORS
GUIDELINES
MANAGEMENT
MORTALITY
BURDEN

Access to Document

10.1111/eci.13595

"Extracellular chromatin burden predicts restenosis and survival after transcatheter aortic valve replacement (TAVI)"
Fejzic, D. (PI)
23/05/20 → 23/05/21
Project: Research

Cite this

Mangold, A., Ondracek, A. S., Hofbauer, T. M., Artner, T., Nechvile, J., Panagiotides, N. G., Mirna, M., Hammerer, M., Fejzic, D., Hoppe, U., Wernly, B., Lauten, A., Alushi, B., Franz, M., Schulze, P. C., Wohlschläger-Krenn, E., Lang, I. M., & Lichtenauer, M. (2021). Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 51(11), e13595. https://doi.org/10.1111/eci.13595

Mangold, Andreas ; Ondracek, Anna S ; Hofbauer, Thomas M et al. / Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement. In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2021 ; Vol. 51, No. 11. pp. e13595.

@article{d263be8efc6142bfb187d4a3021a0ab1,

title = "Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.",

keywords = "NEUTROPHIL EXTRACELLULAR TRAPS, PREDICTORS, GUIDELINES, MANAGEMENT, MORTALITY, BURDEN",

author = "Andreas Mangold and Ondracek, {Anna S} and Hofbauer, {Thomas M} and Tyler Artner and Johanna Nechvile and Panagiotides, {Noel G} and Moritz Mirna and Matthias Hammerer and Dzeneta Fejzic and Uta Hoppe and Bernhard Wernly and Alexander Lauten and Brunilda Alushi and Marcus Franz and Schulze, {Paul C} and Evelyne Wohlschl{\"a}ger-Krenn and Lang, {Irene M} and Michael Lichtenauer",

note = "Mirna; Hammerer; Fejzic; Hoppe; Wernly; Lichtenauer: Paracelsus Med Univ Salzburg, Dept Internal Med 2, Div Cardiol, Salzburg, Austria;",

year = "2021",

doi = "10.1111/eci.13595",

language = "English",

volume = "51",

pages = "e13595",

journal = "EUROPEAN JOURNAL OF CLINICAL INVESTIGATION ",

issn = "0014-2972",

publisher = "Wiley Verlag ",

number = "11",

}

Mangold, A, Ondracek, AS, Hofbauer, TM, Artner, T, Nechvile, J, Panagiotides, NG, Mirna, M , Hammerer, M, Fejzic, D, Hoppe, U , Wernly, B, Lauten, A, Alushi, B, Franz, M, Schulze, PC, Wohlschläger-Krenn, E, Lang, IM & Lichtenauer, M 2021, 'Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.', EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol. 51, no. 11, pp. e13595. https://doi.org/10.1111/eci.13595

Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement. / Mangold, Andreas; Ondracek, Anna S; Hofbauer, Thomas M et al.
In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , Vol. 51, No. 11, 2021, p. e13595.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.

AU - Mangold, Andreas

AU - Ondracek, Anna S

AU - Hofbauer, Thomas M

AU - Artner, Tyler

AU - Nechvile, Johanna

AU - Panagiotides, Noel G

AU - Mirna, Moritz

AU - Hammerer, Matthias

AU - Fejzic, Dzeneta

AU - Hoppe, Uta

AU - Wernly, Bernhard

AU - Lauten, Alexander

AU - Alushi, Brunilda

AU - Franz, Marcus

AU - Schulze, Paul C

AU - Wohlschläger-Krenn, Evelyne

AU - Lang, Irene M

AU - Lichtenauer, Michael

N1 - Mirna; Hammerer; Fejzic; Hoppe; Wernly; Lichtenauer: Paracelsus Med Univ Salzburg, Dept Internal Med 2, Div Cardiol, Salzburg, Austria;

PY - 2021

Y1 - 2021

KW - NEUTROPHIL EXTRACELLULAR TRAPS

KW - PREDICTORS

KW - GUIDELINES

KW - MANAGEMENT

KW - MORTALITY

KW - BURDEN

U2 - 10.1111/eci.13595

DO - 10.1111/eci.13595

M3 - Original Article

C2 - 34101826

SN - 0014-2972

VL - 51

SP - e13595

JO - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

JF - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IS - 11

ER -

Mangold A, Ondracek AS, Hofbauer TM, Artner T, Nechvile J, Panagiotides NG et al. Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION . 2021;51(11):e13595. doi: 10.1111/eci.13595

Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.

Keywords

Access to Document

Projects

"Extracellular chromatin burden predicts restenosis and survival after transcatheter aortic valve replacement (TAVI)"

Cite this